<DOC>
	<DOCNO>NCT02707263</DOCNO>
	<brief_summary>The primary purpose study demonstrate continuous infusion intravenous ( IV ) heparin ( UFH ) Venous thromboembolism ( VTE ) prophylaxis restore prophylactic level heparin high-risk critically ill medical patient compare guideline recommend subcutaneous heparin . Antifactor Xa assay , laboratory test measure anticoagulant activity heparin , ability heparin thin blood , use demonstrate Intravenous administration effective .</brief_summary>
	<brief_title>Effect Intravenous Continuous Infusion Heparin Rates Venous Thromboembolism High-Risk , Critically Ill Patients</brief_title>
	<detailed_description />
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>Admission medical ICU ( MICU ) Highrisk Venous Thromboembolism ( VTE ) ≥ 1 following : Body Mass Index ( BMI ) ≥ 30 kg/m2 Personal family history VTE Receiving vasopressor Indication therapeutic anticoagulation Evidence deep vein thrombosis ( DVT ) ultrasonography admission Indwelling intrathecal , epidural , indwell deep catheter Recent ( &lt; 3 month ) International Society Thrombosis Haemostasis ( ISTH ) major bleeding13 Recent ( &lt; 3 month ) major trauma Recent ( &lt; 3 month ) neurosurgery orthopedic surgery Pregnancy Contraindication heparin heparin product</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>heparin</keyword>
</DOC>